Skip to main content

Molecular Testing and Implications for 1L Therapy in Metastatic EGFR Mutant NSCLC

Author:
Video Duration:
42:53
Perioperative Therapy in Early Stage NSCLC – Implications for Molecular Testing
Oncology Podcast Series

Perioperative Therapy in Early Stage NSCLC – Implications for Molecular Testing

Perioperative Therapy in Early Stage NSCLC- Implications for Molecular Testing Podcast
Oncology Podcast Series

Perioperative Therapy in Early Stage NSCLC- Implications for Molecular Testing Podcast

Molecular Testing and the Implications for Management of ES-NSCLC A Case Base DiscussionPodcast
Oncology Podcast Series

Molecular Testing and the Implications for Management of ES-NSCLC A Case Base DiscussionPodcast

Impact of ctDNAtesting on survival Can MRD testing make a difference for metastatic CRC
Oncology Podcast Series

Impact of ctDNAtesting on survival Can MRD testing make a difference for metastatic CRC

Five Year Update on ADAURA Clinical Trial of Tagrisso in EGFR Early Stage NSCLC
Oncology Podcast Series

Five Year Update on ADAURA Clinical Trial of Tagrisso in EGFR Early Stage NSCLC

Advances in Recurrent NSCLC – Dato-DXd
Oncology Podcast Series

Advances in Recurrent NSCLC – Dato-DXd

The Changing Landscape of MRD Testing in Colorectal CancerPOD
Oncology Podcast Series

The Changing Landscape of MRD Testing in Colorectal CancerPOD

The Changing Landscape of MRD Testing in Colorectal Cancer_0
Oncology Podcast Series

The Changing Landscape of MRD Testing in Colorectal Cancer_0

Fruquintinib The Next Advancement in the Management of Metastatic Colorectal Cancer
Oncology Podcast Series

Fruquintinib The Next Advancement in the Management of Metastatic Colorectal Cancer